Literature DB >> 27249229

Epidemiological Investigation and Risk Factors for Cervical Lesions: Cervical Cancer Screening Among Women in Rural Areas of Henan Province China.

Qingwei Zhang1, Wenyan Xie1, Feng Wang1, Rong Hong Li1, Lina Cui1, Huifen Wang1, Xiuhong Fu1, Jiayu Song2.   

Abstract

BACKGROUND This cross-sectional study aimed to investigate the prevalence of cervical lesions and evaluate risk factors for cervical intraepithelial neoplasia (CIN) among women taking part in cervical cancer screening in rural areas of Henan province, China. MATERIAL AND METHODS Cervical cancer screening using the ThinPrep cytologic test (TCT) and gynecologic exam was conducted on 1315 women age 20-68 years in rural areas of Henan province, China. Colposcopy and biopsies were carried out for histopathologic diagnosis when indicated. Univariate and multivariate logistic regressions were performed to evaluate risk factors associated with cervical lesions. RESULTS Among 1315 women screened, CIN prevalence detected by histopathology was 1.22% (0.38% of CIN 1, 0.76% of CIN 2, and 0.08% of CIN 3). Cervical cancer prevalence was 2.66%. Multivariate analysis confirmed risk factors for cervical lesions included older age (the 21-40 age group vs. the 41-66 age group, OR=0.13, 95% CI: 0.03~0.57), postmenopause (OR=0.11, 95% CI: 0.03~0.45), cervical inflammation (OR=0.06, 95% CI: 0.01~0.31), and smoking (OR=6.78, 95% CI: 1.20~38.23). CONCLUSIONS Older age (41-66 years), presence of HPV infection, postmenopause, cervical inflammation, and smoking are strong risk factors for cervical lesions among women in rural areas of Henan province, China. Particular efforts should be made to provide cervical cancer screening for these women.

Entities:  

Mesh:

Year:  2016        PMID: 27249229      PMCID: PMC4913810          DOI: 10.12659/msm.894663

Source DB:  PubMed          Journal:  Med Sci Monit        ISSN: 1234-1010


Background

Cervical cancer (CCA), generally presenting malignancies in the uterus, cervix and vagina, is the second most common cancer among women, second only to breast cancer [1,2]. About 135 000 new cases occur each year in China, accounting for a third of the global cases; 73–93% of the female reproductive system tumor incidence, which is 6 times higher than in developed countries, and the cases tend to be younger [3]. Over the past 20 years, incidence and mortality of cervical cancer have been rising in China, with the rise of rural areas obviously higher than in cities. Compared with other malignancies, CCA has characteristics with clearer pathogenic factors and longer reversible period of precancerous lesions, and often begins with cervical intraepithelial neoplasia (CIN) accompanied by progressive CIN1, 2, and 3. It was reported that at least 25% of women with CIN 2 and 3 progress to carcinoma in situ or invasive cancer if lesions are untreated [4]. Previous studies suggested that high-risk human papillomavirus (HR-HPV) infection is a main cause of CIN and invasive cervical cancer [5]. However, only a minority of HPV infections progress to CIN or CCA. Other correlative factors, such as oral contraceptive use and pregnancy frequency, affect HPV persistence and development from CIN to invasive CCA [6-8]. Systematic and effective screening, together with early diagnosis and treatment, can save 99% of the patients with CCA [9]; it is significant to reverse cervical precancerous lesions and block development of CCA by early screening and effective prevention. Due to active CCA prevention and screening in China, the mortality rate of CCA decreased in the 1990s, but had an increasing trend in recent years. The CCA screening work throughout China has not been evenly distributed and various regions have different trends. There has been no systemic and comprehensive research on risk factors for cervical lesions (including CIN and CCA) among women living in the rural areas of Luohe city, Henan province, central China, which has a high incidence of CCA. In this study, 1315 women were recruited for CCA screening. All women were offered gynecological examinations, HPV test, and ThinPrep cytology test (TCT) to estimate prevalence of cervical lesions and evaluate risk factors for cervical lesions, which provides evidence to nationwide screening strategies of the cervical cancer program.

Material and Methods

Subjects and study design

In rural areas of Henan province, China, 1315 women aged between 21 to 68 years old (mean years=41.84±7.80) attended cervical cancer screening. Inclusion criteria were: (1) current or past sexual activity; (2) not pregnant at the time of enrollment; (3) never been screened or treated for cervical cancer; (4) had not undergone a total uterus or cervix resection. All of the recruited subjects were familiar with the purpose and procedures of the study and signed informed consent forms before the study. Exclusion criteria were: difficulties in obtaining information; unanalyzable samples; pregnant women; history of uterectomy; and refusal to participate. The present study was conducted in accordance with the Declaration of Helsinki. All study protocols were approved by the Ethics Committee of the First Affiliated Hospital of Luohe Medical College. All the subjects completed the structured case report form (CRF) questionnaires for cervical cancer screening, including socio-demographic information, reproductive history, sexual behavior, birth control measures, medical history, gynecologic examination history, TCT and histologic test results, and demographic data of husbands. Socio-demographic information collected from each woman included age, education level, occupation, marital status, economic conditions, and living situation. Information was also recorded on reproductive history and sexual characteristics, including menarche age, length of menstrual cycle, menstrual capacity, menopausal age, number of pregnancies, number of abortions, delivery times, birth control measures, sanitary conditions of sexual life, and cervical inflammation. Medical history included any history of gynecological tumors, such as uterine sarcoma, fallopian tube tumors, ovary benign tumors or cancer, and vulvar carcinoma.

Measurements

TCT and histopathologic diagnosis

Exfoliated cervical cells were collected from the ectocervix and endocervix with a plastic Ayres’s spatula and cytobrush. The collected cells were analyzed by TCT. Cytological findings were diagnosed according to the Bethesda classification system [10] and were classified as follows: a) negative; b) atypical squamous cells of undetermined significance (ASCUS); c) low-grade squamous intra epithelial lesion (LSIL); d) atypical squamous cells that cannot exclude HSIL (ASC-H); e) high-grade squamous intraepithelial lesion (HSIL). If TCT results were abnormal, participates were referred for colposcopic exams. A histologic test by biopsy was performed to determine CIN grade. CIN grades were categorized as CIN1, CIN2, and CIN3 according to Richard’s classification [11], in which CIN2 and CIN3 are defined as HSIL.

HPV detection

HPV DNA testing was conducted using polymerase chain reaction (PCR) and HPV types were detected by a commercial HPV genotyping kit (Yaneng Bioscience (Shenzhen) Co., Ltd, China), as previously described [12].

Statistical analysis

Statistical analyses were performed using SPSS software (IBM Corporation, Armonk, New York, USA) (version 19.0). Count data and measurement data of participants’ characteristics were examined by χ2 test and t test, respectively. Backward univariate and multivariate logistic regression model was used to assess the relationship between cervical lesions and potential risk factors. P-values were two-sided, and statistical significance was defined as p<0.05.

Results

A total of 1315 women from the rural areas of Henan province, China, participated in the screening study. Of the subjects, 5 women (0.38%) were identified by pathologic diagnosis as CIN1, 10 (0.76%) as CIN2, 1 (0.076%) as CIN3, and 35 (2.66%) as cervical cancer. The prevalence of cervical lesions in different age groups is shown in Table 1. There were significant differences among the age groups in terms of the prevalence of cervical lesions (χ2=357.000, p=0.000). The peak age range of onset of CIN was between the ages of 30 and 40 years, and 41–55 years range for the onset of CCA.
Table 1

Prevalence of cervical lesions in different age groups.

Age groupCCA (%)CIN (%)NormalTotal
20–291 (1.49)0 (0)6667
30–355 (2.78)5 (2.78)170180
36–407 (2.57)6 (2.21)259272
41–459 (3.26)2 (0.72)265276
46–508 (2.80)2 (0.70)276286
51–553 (3)1 (1)96100
56–601 (1.06)0 (0)9394
≥611 (2.50)0 (0)3940

There were significant differences among the age groups in terms of the prevalence of cervical lesions (χ2=357.000, p=0.000). CCA – cervical cancer; CIN – cervical intraepithelial neoplasia. Statistical analyses were performed using χ2 test and t test.

The mean age of the subjects with cervical lesions was 41.84±7.80 years, with 36.80±7.19 years for CIN1(range: 30–49 years), 40.10±6.59 years for CIN2 (range: 30–52 years), 41 years for CIN3 (only 1 subject), and 43.09±8.10 for CCA (range: 23–66) (Table 2). The results indicated that with increasing age, the cervical lesions exacerbated. In all subjects, 33 women were positive for HPV infection and the prevalence was 2.51% (Table 3). In detail, the crude prevalence of HPV was 0.4% for the normal or inflammation of the women, 20% for CIN1, 30% for CIN2, and 66.7% for CIN3 and CCA. HPV infection had significant differences between women with the cervical lesions (n=28) and those with normal and inflammatory histology (n=5) (χ2=33.000, p<0.01). Similarly, there was a significant difference among all the groups (χ2=132.000, p<0.01).
Table 2

Distribution of the average age of the subjects with cervical lesions.

Histological gradeAge of patients
NumberMinMaxAverage
CIN15304936.80±7.19
CIN210305240.10±6.59
CIN31414141
CCA35236643.09±8.10
Total51306641.84±7.80
Table 3

HPV infection at all levels of the cervical lesions.

Histological gradeHPV (DNA test)TotleInfection rate (%)
PositiveNegtive
Normal or inflammation5125912640.40
CIN114520.00
CIN2371030.00
CIN3101100.00
CCA23123565.71
Total33128213152.51

HPV infection had significant differences between women with the cervical lesions (including CIN and CCA) (n=28) and those with normal and inflammatory histology (n=5) (χ2=33.000, p<0.01). There was a significant difference among all the groups (χ2=132.000, p<0.01). Statistical analyses were performed using χ2 test and t test.

Independent variables and their corresponding encoding number are shown in Table 4. A univariate logistic regression analysis revealed that the age group of 41–66 years (compared with the age group of 21–40 years) (P=0.023), annual income less than 30 000 yuan (P=0.044), HPV infection (P= 0.000), postmenopause (P=0.002), age at first pregnancy below 20 years old (P=0.024), cervical inflammation (P= 0.000), smoking (P=0.000), and breakdown of marital relations (P=0.038) as risk factors significantly associated with presence of the cervical lesions (Table 5). Furthermore, risk factors that remained significant by multivariate logistic regression analysis were being in the age group of 41–66 years (OR=0.131, 95% CI: 0.030–0.573, compared with the age group of 21–40 years), HPV infection (OR=260.630, 95% CI: 19.970–3401.510), postmenopause (OR=0.108, 95% CI: 0.026–0.452), cervical inflammation (OR=0.061, 95% CI: 0.012–0.313), and smoking (OR=6.778, 95% CI: 1.202–38.226) (Table 6).
Table 4

Independent variables and their corresponding encoding number.

Independent variableNumberVariable code
Socio-demographic information
AgeX10=41–66; 1=21–40
Education levelX20=Illiteracy and primary school;1=Junior middle school or above
Marital statusX30=Married; 1=Single
OccupationX40=House wife; 1=Female professional
Economic conditionsX50=Less than or equal to 30000 yuan;1=More than 30000 yuan
Living situationX60=Living with family; 1=Others
Physical condition and medical history
HPV infectionX71=Yes; 2=No
Medical historyX81=Yes; 2=No
Cervical inflammationX91=Yes; 2=No
Menstrual and menopausal history
Menarche ageX100=Less than or equal to 16 years old;1=More than 16 years old
Length of menstrual cycleX111=Regular; 2=Random
Menstrual capacityX121=Little or much; 2=Modest
PostmenopauseX130=No; 1=Yes
Sexual characteristics
The first sexual behaviorX141=Less than or equal to 20 years old;2=More than 20 years old
Frequency of sex every monthX151=Less than or equal to 4 times;2=More than 4 times
Sexual partnersX161=Only one; 2=More than one
Reproductive history
Age at first pregnancyX171=Less than or equal to 20 years old;2=More than 20 years old
Age of first deliveryX181=Less than or equal to 20 years old;2=More than 20 years old
Pregnant frequencyX191=More than 3 times;2=Less than or equal to 3 times
Birth control measuresX201=Yes; 2=No
Life and behavior way
SmokingX211=Yes; 2=No
Passive smokingX221=Yes; 2=No
Family statusX231=Satisfied; 2=Dissatisfied
Unfortunate events in lifeX241=Yes; 2=No
Breakdown of marital relationsX251=Satisfied; 2=Dissatisfied
Husbands’ cases
Education levelX260=Illiteracy and primary school;1=Junior middle school or above
Living situationX270=Living with family; 1=Others
OccupationX281=Farmer; 2=Others
History of penile carcinoma/prostate cancerX291=Yes; 2=No
Redundant prepuceX301=Yes; 2=No
Sanitary conditions of sexual lifeX311=Yes; 2=No
History of venereal diseasesX321=Yes; 2=No
Cervical lesions (CCA and CIN)Y11=Yes; 2=No
Table 5

Risk factors for cervical lesions assessed by univariate logistic regression.

VariablesOR95% CIP
LowerUpper
X13.4261.1839.9170.023
X23.2100.42224.4250.260
X30.0000.0000.998
X421082869.070.0000.997
X52.7781.0277.5110.044
X60.0000.0000.998
X720.6336.72263.332<0.001
X820272625.470.0000.998
X926.0958.89376.570<0.001
X101.1440.3234.0500.834
X111.1540.3983.3450.792
X121.2580.2735.7960.768
X134.8321.78313.0920.002
X142.5980.9686.9750.058
X151.9600.7255.3020.185
X161.2020.3404.2460.776
X173.7521.18911.8350.024
X181.8160.23514.0430.568
X191.4820.4205.3230.541
X201.0530.3902,8440.920
X2129.83810.47984.965<0.001
X221.1000.3523.4370.869
X233.4740.98512.2490.053
X242.7300.35920.7810.332
X258.5901.13165.2320.038
X2621485949.690.0000.997
X2720513966.250.0000.998
X281.1670.4223.2330.766
X2920612119.200.0000.998
X301.8960.4248.4720.402
X311.5290.3436.8130.578
X3220005880.400.0000.999

Statistical analyses were performed using backward univariate and multivariate logistic regression.

Table 6

Risk factors for cervical lesions assessed by multiple logistic regression.

VariablesOR95% CIP
LowerUpper
X10.1310.0300.5730.007
X50.7580.1883.0590.697
X7260.63019.9703401.510<0.001
X90.0610.0120.3130.001
X130.1080.026.4520.002
X170.6160.0844.5430.635
X216.7781.20238.2260.030
X224.9800.55644.6390.151

Statistical analyses were performed using backward univariate and multivariate logistic regression.

Discussion

We presented the first large-scale cervical cancer screening study in rural areas of Henan province, China; 1315 women aged 21–68 years were eligible to participate in the study. The prevalence of cervical lesions was 3.88%, among which the prevalence of CIN1, 2, 3, and cervical cancer was 0.38%, 0.76%, 0.076%, and 2.66%, respectively. The prevalence of cervical lesions had a declining trend with age (shown in Table 1). The peak age range of onset of CIN was between the ages of 30 and 40 years, and 41–55 years range for the onset of CCA. With age, cervical lesions became more serious, which is related to the long process of development from CIN to CCA, which takes about 10–15 years. The prevalence of precancerous cervical lesions (CIN1, 2, and 3) in this screening study (1.22%) was higher than the previous report in 2009 (0.20%) [13], as a result of a relatively smaller sample size in the present study. The prevalence of CCA was 2.66%, comparable to rates reported in the China Cancer Registration Annual Report 2014, in which 219 cancer registries were included; the incidence of CCA was 9.84 per 100 000 in China (2.48% in urban and 2.49% in rural areas) [14]. According to a survey of the Cancer Institute and Hospital, Chinese Academy of Medical Sciences, the patients under the age of 35 years accounted for 5.01% of all cervical cancer patients in the 1990s; but, the proportion increased distinctly to 9.88% at the start of this century [15]. Previous reports suggested that the prevalence of CCA was rising in younger women [16,17]. The results of our screening study indicated that cervical cancer screening intervention should be conducted for women from the age of 30. Consistent with the previous studies [18,19], age 41–66 years was identified as a significant risk factor for cervical lesions in the present study, among which the subjects aged 41–55 years were vulnerable to CCA. Other studies had also revealed that older age and postmenopause were significant risk factors for development of CCA [20,21]. There was a significant association between abnormal TCT results and gynecologic infections. Cervical inflammation was significantly related to cervical lesions, supporting the previous findings [22,23]. Some epidemiologic evidence suggested that there was a higher incidence of CCA in women with chronic cervicitis than in the general population [24]. If chronic cervicitis cannot be cured as early as possible, inflammation recurs and persists, resulting in atypical squamous epithelial hyperplasia and progression to CCA. Additionally, chronic cervicitis decreases cellular immunity, inducing HPV infection that is not easy cure and persistent infection. Therefore, cervical inflammation can be considered as a cofactor contributing to HPV infection development to high-grade CIN and CCA [25]. Our results showed that the postmenopausal women were inclined to have CCA. Although the postmenopausal women with cervical lesions had no obvious symptoms, the incidence of abnormal cervical cytology was higher than the non-menopausal group in our study. Due to estrogen decrease, the vaginal wall beginning to thin, and glycogen in the epithelial cells decline, the postmenopausal women were susceptible to senile vaginitis, which further induced abnormal cervical cytology. Furthermore, Ter Harmsel’s et al. findings indicated that postmenopausal women tended to develop persistent HPV infection and develop high-grade CIN and CCA [26]. Consequently, it is of great significance for prevention of cervical lesions that postmenopausal women with reproductive tract HPV infection get early treatment. Additionally, a significant association between smoking and cervical lesions was identified in the present study, as multiple studies have already demonstrated [27,28]. Chemical carcinogens in tobacco, such as cotinine and nicotine, were found to exist in cervix mucosae of smoking women [29], probably exerting a series of carcinogenic effects by activating nitrosamines and causing DNA damage, and may destroy the local immune defense in the cervical epithelium [30]. Thus, smoking has a serious impact on the development of cervical lesions, consistent with findings indicating that smoking cessation benefits CIN regression [31]. However, the biological mechanism by which smoking facilitates development of cervical cancer needs further study.

Conclusions

We presented the first large-scale cervical cancer screening study in rural areas of Henan province, China. The prevalence of cervical lesions was relatively high (3.88%). Women aged 41–66 years, with HPV infection, cervical inflammation, smoking, and those reporting postmenopause have strong risk for cervical lesions in this study. Particular efforts should be taken for cervical cancer screening in these women. Moreover, our data provide evidence for the primary screening of cervical cancer in rural areas.
  26 in total

1.  China's plans to curb cervical cancer.

Authors:  Chihua Wen
Journal:  Lancet Oncol       Date:  2005-03       Impact factor: 41.316

2.  [Prevalence of cervical infection by human papillomavirus and cervical intraepithelial neoplasia in HIV-positive and negative women].

Authors:  Benito Pio Vitorio Ceccato Junior; Ana Paula Ceccato Lopes; Lorena Fiorini Nascimento; Luísa Magalhães Novaes; Victor Hugo Melo
Journal:  Rev Bras Ginecol Obstet       Date:  2015-04

3.  Metabolomics analysis of cervical cancer, cervical intraepithelial neoplasia and chronic cervicitis by 1H NMR spectroscopy.

Authors:  N Ye; C Liu; P Shi
Journal:  Eur J Gynaecol Oncol       Date:  2015       Impact factor: 0.196

4.  An association of cervical inflammation with high-grade cervical neoplasia in women infected with oncogenic human papillomavirus (HPV).

Authors:  P E Castle; S L Hillier; L K Rabe; A Hildesheim; R Herrero; M C Bratti; M E Sherman; R D Burk; A C Rodriguez; M Alfaro; M L Hutchinson; J Morales; M Schiffman
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2001-10       Impact factor: 4.254

5.  Molecular transitions from papillomavirus infection to cervical precancer and cancer: Role of stromal estrogen receptor signaling.

Authors:  Johan A den Boon; Dohun Pyeon; Sophia S Wang; Mark Horswill; Mark Schiffman; Mark Sherman; Rosemary E Zuna; Zhishi Wang; Stephen M Hewitt; Rachel Pearson; Meghan Schott; Lisa Chung; Qiuling He; Paul Lambert; Joan Walker; Michael A Newton; Nicolas Wentzensen; Paul Ahlquist
Journal:  Proc Natl Acad Sci U S A       Date:  2015-06-08       Impact factor: 11.205

Review 6.  HPV-related squamous neoplasia of the lower anogenital tract: an update and review of recent guidelines.

Authors:  Kruti P Maniar; Ritu Nayar
Journal:  Adv Anat Pathol       Date:  2014-09       Impact factor: 3.875

7.  Environmental exposure to cooking oil fumes and cervical intraepithelial neoplasm.

Authors:  Ming-Tsang Wu; Li-Hung Lee; Chi-Kung Ho; Su-Chu Wu; Long-Yau Lin; Bi-Hua Cheng; Chia-Ling Liu; Chun-Yuh Yang; Hsiu-Ting Tsai; Trong-Neng Wu
Journal:  Environ Res       Date:  2004-01       Impact factor: 6.498

8.  Smoking, diet, pregnancy and oral contraceptive use as risk factors for cervical intra-epithelial neoplasia in relation to human papillomavirus infection.

Authors:  L Kjellberg; G Hallmans; A M Ahren; R Johansson; F Bergman; G Wadell; T Angström; J Dillner
Journal:  Br J Cancer       Date:  2000-04       Impact factor: 7.640

9.  Risk of preterm delivery with increasing depth of excision for cervical intraepithelial neoplasia in England: nested case-control study.

Authors:  Alejandra Castanon; Rebecca Landy; Peter Brocklehurst; Heather Evans; Donald Peebles; Naveena Singh; Patrick Walker; Julietta Patnick; Peter Sasieni
Journal:  BMJ       Date:  2014-11-05

10.  Evaluation of HPV infection and smoking status impacts on cell proliferation in epithelial layers of cervical neoplasia.

Authors:  Martial Guillaud; Timon P H Buys; Anita Carraro; Jagoda Korbelik; Michele Follen; Michael Scheurer; Karen Adler Storthz; Dirk van Niekerk; Calum E MacAulay
Journal:  PLoS One       Date:  2014-09-11       Impact factor: 3.240

View more
  8 in total

1.  [RNA interference of HERC4 inhibits proliferation, apoptosis and migration of cervical cancer Hela cells].

Authors:  Min Wei; Yan-Ling Zhang; Lan Chen; Cui-Xia Cai; Han-Duo Wang
Journal:  Nan Fang Yi Ke Da Xue Xue Bao       Date:  2016-02-20

Review 2.  Inflammation related miRNAs as an important player between obesity and cancers.

Authors:  Morteza Gholami; Bagher Larijani; Zhila Zahedi; Fatemeh Mahmoudian; Samira Bahrami; Sima Parvizi Omran; Zahra Saadatian; Shirin Hasani-Ranjbar; Reza Taslimi; Milad Bastami; Mahsa M Amoli
Journal:  J Diabetes Metab Disord       Date:  2019-11-26

3.  MicroRNA-30e Functions as a Tumor Suppressor in Cervical Carcinoma Cells through Targeting GALNT7.

Authors:  Huijuan Wu; Jun Chen; Dan Li; Xiangyu Liu; Lei Li; Ke Wang
Journal:  Transl Oncol       Date:  2017-09-27       Impact factor: 4.243

4.  Distribution and Determinants of Unmet Need for Supportive Care Among Women with Breast Cancer in China.

Authors:  Shouhua Wang; Yanqing Li; Chaozhuo Li; Yijun Qiao; Shuling He
Journal:  Med Sci Monit       Date:  2018-03-21

5.  Precancerous Cervical Lesions Among HIV-Infected Women Attending HIV Care and Treatment Clinics in Southwest Ethiopia: A Cross-Sectional Study.

Authors:  Lidiya Gutema Lemu; Biruktawit Fekade Woldu; Natnael Eshetu Teke; Nardos Delelegn Bogale; Ermias Ayalew Wondimenew
Journal:  Int J Womens Health       Date:  2021-03-03

6.  Nanomechanical Characteristics of Cervical Cancer and Cervical Intraepithelial Neoplasia Revealed by Atomic Force Microscopy.

Authors:  Yueyi Cui; Xuejie Zhang; Ke You; Yanli Guo; Congrong Liu; Xiaohong Fang; Li Geng
Journal:  Med Sci Monit       Date:  2017-08-31

Review 7.  The Associations between Toll-Like Receptor 9 Gene Polymorphisms and Cervical Cancer Susceptibility.

Authors:  Sijuan Tian; Liping Zhang; Ting Yang; Xing Wei; Li Zhang; Yang Yu; Yang Li; Di Cao; Xiaofeng Yang
Journal:  Mediators Inflamm       Date:  2018-07-25       Impact factor: 4.711

8.  Correlation of APOBEC3G Polymorphism with Human Papillomavirus (HPV) Persistent Infection and Progression of Cervical Lesions.

Authors:  Shuang Sui; Hongxiang Chen; Lili Han; Lin Wang; Mayineur Niyazi; Kaichun Zhu
Journal:  Med Sci Monit       Date:  2019-09-17
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.